Merriman Curhan Ford reiterates a 'Buy' rating on Regeneron (Nasdaq: REGN), raising target range to $34-35 from $29-31.

Merriman analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE